An exploration of potential negative effects from delays in measure maintenance when changes in clinical evidence affect measure use found that delays may affect patient care and outcomes. To be ...

Less than 2 decades after publication of the National Academy of Medicine's (formerly the Institute of Medicine) Crossing the Quality Chasm: A New Health System for the 21st Century, quality ...

Quality evidence is needed to support a new Medicare Part D medication therapy management (MTM) program performance measure, prompting a scoping review on MTM services and associated outcomes.

We are at an inflection point in our efforts to measure the quality of U.S. health care. Most medical professionals accept that rigorous quality measurement is essential to improving care and ...

Some programs would be able to continue using one of three current systems through 2029 ...

Rising cancer care costs are no longer sustainable. Medical oncologists must focus on providing the maximum value to their patients; improving short-term, intermediate and long-term outcomes; and ...

The time is ripe to reexamine what the past 15 years of investment in Medicaid quality measurements has yielded and to identify opportunities to better measure what matters to Medicaid members. In ...

The real “pain point” for providers should be inadequate systems, not quality oversight. I’m referring to Kimberly Marselas’ recent article that portrays the Center for Medicare & Medicaid Services’ ...